Skip to the page

Data / Drug companies / Combe Incorporated

Combe Incorporated: 8 products in the FDA NDC directory, labeler code 11509

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Combe Incorporated (labeler code 11509) lists 8 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 8 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 8, 2020.

The request: Watch Combe Incorporated (FDA labeler code 11509): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
11509
Products in commercial distribution
8
Packages
8
Finished drugs by generic name
5
Prescription products
0
Over the counter products
8
Flagged as original packager
8 of 8 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
March 1, 1995
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs562.5%
Generic drugs (ANDA)337.5%

Products by type

TypeProductsShare
Over the counter drugs8100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Cream450%
Cloth225%
Kit112.5%
Ointment112.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Vagisil brand vagistat11509-0825CreamGeneric drugs (ANDA)October 8, 2020
Vagistat11509-0426OintmentGeneric drugs (ANDA)July 29, 2020
Vagistat 311509-0081KitGeneric drugs (ANDA)March 27, 2018
Vagisil Anti-Itch Creme Maximum Strength Sensitive Skin Formula11509-5101CreamOver the counter monograph drugsJanuary 30, 2016
VAGISIL Anti-Itch Creme Regular Strength11509-5103CreamOver the counter monograph drugsJanuary 1, 2016
VAGISIL Anti-Itch Medicated Wipes Maximum Strength11509-5058ClothOver the counter monograph drugsJune 28, 2005
VAGISIL Anti-Itch Medicated Wipes Maximum Strength11509-5035ClothOver the counter monograph drugsJune 28, 2005
VAGISIL Anti-Itch Medicated Creme Maximum Strength11509-4402CreamOver the counter monograph drugsMarch 1, 1995

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.